Lennox Gastaut Syndrome - 19 Studies Found
| Active, not recruiting |
: Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome : Lennox-Gastaut Syndrome : 2014-06-10 : Drug: Rufinamide Administration of Inoveron 100mg or 200mg Tablets |
| Completed |
: A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults :
: 2014-08-21 :
|
| Completed |
: A Long Term Extension Study of E2080 in Lennox-Gastaut Patients : Lennox-Gastaut Syndrome : 2010-06-14 : Drug: E2080 The target dosage is approximately 45 mg/kg/day, taken orally twice a day. |
| Completed |
: Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy :
: 2016-01-12 : Drug: Fenfluramine study of efficacy and safety of add-on fenfluramine at different dosages in refractor |
| Completed |
: A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome :
: 2005-10-07 : Drug: topiramate |
| Terminated |
: Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS : Epilepsy : 2012-05-17 : Drug: retigabine/ezogabine retigabine/ezogabine will be administered three times a day (TID) as add-on t |
| Completed |
: Ketogenic Diet for Child Epilepsy and Seizure Control :
|
| Completed |
: A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures :
: 2006-02-24 : Drug: Topiramate Individualization of the treatment should begin from 25 mg for 1 week. |
| Terminated |
: Study in Pediatric Subjects With Epilepsy : Epilepsy : 2011-12-01 : Drug: ezogabine/retigabine ezogabine dose escalation |